Notice of Intent to Sole Source – TheraDoc subscription
ID: NOI-CC-25-001233Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

Original Source

https://sam.gov/opp/0d3f94d1cd38468585d1d6c6eaf27747/view
Timeline
    Description

    The National Institutes of Health (NIH) Clinical Center intends to award a firm fixed-price purchase order for subscription services related to the TheraDoc application, exclusively owned by Premier Healthcare LLC. This procurement aims to secure applications, support, maintenance, and training for the TheraDoc clinical surveillance solution, which is critical for enhancing healthcare delivery and patient safety. The acquisition will follow the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, allowing for a sole-source solicitation due to the unique nature of the services required. Interested parties may express their capabilities and submit comments to the NIH by November 21, 2024, with inquiries directed to Ryssa Nix at Ryssa.nix@nih.gov.

    Point(s) of Contact
    Christopher Lauver
    christopher.lauver@nih.gov
    Files
    Title
    Posted
    NOI to sole source.pdf
    The National Institutes of Health (NIH) Clinical Center is issuing a Notice of Intent to Sole Source for a TheraDoc subscription, seeking to acquire subscription services from Premier Healthcare LLC. This document is not a request for quotations, as a solicitation will not be issued. The proposal involves a firm fixed-price purchase order to provide applications, support, maintenance, and training related to the TheraDoc clinical surveillance solution, which is exclusively owned by Premier Healthcare. The acquisition follows the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, allowing for a single-source solicitation due to the unique circumstances. Interested parties can respond with their capabilities, but the final decision to compete or not will rest with the government. Comments can be submitted by November 21, 2024. The posting includes relevant codes for NAICS and PSC classifications related to IT and computer services. Overall, this notice indicates the NIH's intent to streamline procurement for critical health technology services in a focused manner.
    Lifecycle
    Title
    Type
    Notice of Intent to Sole Source – TheraDoc subscription
    Currently viewing
    Special Notice
    Similar Opportunities
    Notice of Intent to Sole Source – Cardinal Health, Inc.
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a fixed-price purchase order to Cardinal Health, Inc. for the procurement of Floxuridine Vials, specifically for patient care at the NIH Clinical Center in Bethesda, Maryland. The requirement includes 10 units of Floxuridine for Injection, catalog number 0143-9270-01, which is exclusively distributed by Cardinal Health, Inc. in the United States, highlighting the critical nature of this medication for patient treatment. Interested parties may express their interest and capabilities to Kristin Nagashima at kristin.nagashima@nih.gov by February 10, 2025, at 4 PM EST, as this acquisition is being conducted under the Simplified Acquisition Procedures of the Federal Acquisition Regulation.
    Hardy Diagnostic Reagents and Supplies
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract to Hardy Diagnostics for the procurement of culture media and organism supplies necessary for cGMP Sterility Testing Services. The primary objective is to ensure compliance with FDA regulations by utilizing cGMP quality materials that have been rigorously validated, as these supplies are critical for the isolation and identification of pathogens affecting critically ill patients. The contract will cover a base period of twelve months with an option for an additional three months, and interested vendors capable of providing similar products are encouraged to submit capability statements by the specified deadline. For further inquiries, potential respondents may contact Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov.
    RENEWAL OF SOFTWARE LICENSE, MAINTENANCE AND SUPPORT FOR GENEDATA ANALYST (AMBIS 2253271)
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract for the renewal of the Genedata Analyst software license, along with maintenance and support services. This procurement is essential for the ongoing bioinformatics and statistical analysis of large ‘multi-omics’ datasets, which are critical for understanding immune responses in human samples during influenza A virus vaccination and infection studies. The software plays a vital role in the research conducted by the Viral Pathogenesis and Evolution Section, aiding in the development of novel vaccines and antiviral therapies. Interested vendors must submit capability statements via the NIH electronic Simplified Acquisition Submission System (eSASS) by 4:00 PM EST on January 31, 2025, and can contact Rita Davis at rita.davis@nih.gov or Tonia Alexander at talexander@niaid.nih.gov for further information.
    Diagnostic laboratory Testing
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Antech Diagnostics, Inc. for one year of diagnostic laboratory testing services at the NIH Animal Center in Poolesville, Maryland. The required services include clinical pathological evaluations of blood and other bodily fluids from non-human primates, encompassing tests such as Complete Blood Counts, Blood Chemistry Analysis, and Urinalysis, which are critical for ensuring accurate and timely results in research. This procurement is justified under the statutory authority allowing non-competitive procurement due to the necessity for continuity in laboratory services, and interested parties are invited to submit capability statements by January 23, 2023, to Calvin Robinson at calvin.robinson@nih.gov for consideration.
    Haemonetics Corporation - Preventative Maintenance Agreement
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole source contract to Haemonetics Corporation for a Preventative Maintenance Agreement concerning two Automated Cell Processors ACP® 215. The contract will cover preventative maintenance services for a base year and three optional one-year periods, ensuring that the equipment operates in compliance with FDA regulations and manufacturer specifications, which is critical for supporting patient care through blood product services. Interested parties capable of providing similar services may submit a capability statement by January 27, 2025, to Emeka Onyejekwe at emeka.onyejekwe@nih.gov for consideration, although the decision to pursue competitive procurement remains at the discretion of the government.
    Preventative Maintenance Agreement
    Health And Human Services, Department Of
    Solicitation Notice: HEALTH AND HUMAN SERVICES, DEPARTMENT OF - NATIONAL INSTITUTES OF HEALTH is seeking a Preventative Maintenance Agreement for integration systems used in the current Operating Rooms to the Education Room in Bethesda, Maryland, United States. The purpose of this agreement is to support the existing systems and prevent delay in case the integration system goes down. The agreement requires remote monitoring capabilities, collaboration among NIH and other research institutes, and web-based and teleconference consultation and collaboration. The contract duration includes a base year and two option years. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13. Interested parties may respond to this notice, and the Government will determine whether to compete the requirement based on the responses received.
    Notice of Intent for Preventative Maintenance and Repair for LSR Fortessa, FACSCanto II, and Various Lasers
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Becton, Dickinson and Company (BD Biosciences) for preventative maintenance and repair services for various scientific equipment. The procurement includes two preventive maintenance inspections, software updates, unlimited service visits by OEM technicians, guaranteed OEM replacement parts, and emergency response support compliant with Biosafety Level 2 standards. This maintenance is crucial for ensuring the operational efficiency and safety of research equipment used in critical health studies. Interested vendors may submit capability statements via the NIAID electronic Submission System by 10:00 AM EST on January 31, 2025, with all submissions referencing Solicitation Number NOI-NIAID-25-2251079. For further inquiries, contact Leah Hinson at leah.hinson@nih.gov.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    A--Clinical Research Operations and Management Support (CROMS)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the Clinical Research Operations and Management Support (CROMS) contract. This procurement aims to enhance the oversight and efficiency of clinical studies by providing essential systems, tools, and expert resources for data management, site monitoring, and regulatory compliance. The contract is critical for ensuring adherence to federal regulations regarding human subjects and data privacy, thereby safeguarding sensitive health-related information. Interested parties should note that the solicitation date has been updated to December 13, 2024, and must register in the System for Award Management (SAM) prior to contract award. For further inquiries, contact Natalie Bruning at natalie.bruning@nih.gov or Tara C. Knox at knoxt@nhlbi.nih.gov.
    SPEEDBioSystems TURBO293 Transfection Reagents
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a procurement contract with SPEED BioSystems, LLC for the acquisition of TURBO293 Transfection Reagents. The requirement includes 46 units of the TURBO293 TRANSFECTION REAGENT (20ML), which are critical for ongoing research and development activities at the Vaccine Research Center in Bethesda, Maryland. This procurement is being conducted on a sole-source basis due to SPEED BioSystems, LLC being the sole owner and developer of the required reagents, ensuring continuity and compatibility with existing protocols. Interested vendors may submit their capabilities statements to Jessica Emerson at jessica.emerson@nih.gov by the specified deadline for consideration, although the government is under no obligation to award a contract based on the responses received.